about
A placebo controlled double-blind evaluation of the pharmacodynamics of fengabine vs amitriptyline following single and multiple doses in elderly volunteers.Oxaprozin pharmacokinetics in the elderlyBenzodiazepines in epilepsy: pharmacology and pharmacokineticsCognitive decline with nortriptyline use in a patient with dementia of the Alzheimer's typeReview of one year of drug prescribing for the elderly in a hospital clinic.Medication and the elderly. Issues of prescription and use.Risks of combined alcohol/medication use in older adults.Diphenhydramine: pharmacokinetics and pharmacodynamics in elderly adults, young adults, and children.Single dose pharmacokinetics and pharmacodynamics of oral oxazepam in very elderly institutionalised subjectsA pharmacokinetic study of cilazapril in elderly and young volunteersAmiloride disposition in geriatric patients: importance of renal functionThe effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein.Pharmacokinetics of erythromycin in patients with severe cirrhosis. Respective influence of decreased serum binding and impaired liver metabolic capacity.The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.The effect of ageing on the disposition of nifedipine and atenololSuspected adverse drug reactions in elderly patients reported to the Committee on Safety of MedicinesThe influence of age and smoking on the elimination of disopyramide.Pharmacokinetics of the trimethoprim-sulphamethoxazole combination in the elderlyAge and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilatAge and the pharmacokinetics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacityPharmacokinetics of ketoprofen in the elderly.Differential effect of isoniazid on triazolam oxidation and oxazepam conjugation.Pharmacokinetics of valproic acid in the elderly.Pharmacokinetics of aztreonam in elderly male volunteersAppropriate health care for older women.Midazolam: the first water-soluble benzodiazepine. Pharmacology, pharmacokinetics and efficacy in insomnia and anesthesia.Human pharmacogenomic variations and their implications for antifungal efficacy.Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects.Cognitive toxicity of drugs used in the elderly.Prescribing for the elderly patient: why do we need to exercise caution?Effects of age and gender on pharmacokinetics of cefepimePharmacodynamics of milnacipran in young and elderly volunteers.Safe and Effective Prescribing for the Elderly: A look at factors linked with adverse drug reactionsA review of the evidence concerning hepatic glutathione depletion and susceptibility to hepatotoxicity after paracetamol overdoseA systematic study on drug-response associated genes using baseline gene expressions of the Cancer Cell Line Encyclopedia.Management of opioid analgesic overdosePopulation Pharmacokinetic Modeling of Tribendimidine Metabolites in Opisthorchis viverrini-Infected Adults.Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patientsNow or never: optimal antihypertensive therapy in the elderly.
P2860
Q24541293-7A291166-FBE8-4BAE-B24F-81D4D0843A87Q24544096-6F2AD7F9-C93C-4C1E-B5FB-26A896CF3A60Q28274897-18025EB9-A316-4A82-80E3-A7D3D23404E1Q28324503-65ADF4FE-1650-4FEE-B706-F488DA002EFBQ33615162-22E5BE6D-F31E-4D21-9F3C-D349C8C4E788Q33630080-59DACE13-E215-4F50-AB85-0FE0E706937AQ33776601-8C857FE6-3D5A-45CE-B747-F40F1D5BB7A9Q34037717-82AA50CE-D30E-44E9-91F1-07BCEE2AFA08Q34358937-D1A7E7E4-EBF2-4E08-997C-BEB2F543215DQ34397114-666B981D-5158-4304-99D4-2EF41593AF70Q34398087-EB1EA102-FDB7-4945-B48D-FAA139AFA163Q34398214-BA37C09D-AF4E-401A-BC80-E150F7310390Q34416606-3C157C1D-5FED-4C5D-A6B1-B12DEE1ED7E7Q34416893-4E36FCCA-3390-4D2D-A2C3-FB0FDAC3BF6DQ34417199-EFEDDAF1-00D3-4141-BA5F-F3FC175C1E77Q34418047-27681704-E11C-4DA2-A1B3-710089597566Q34446722-7B756F3C-D1D9-4002-ABB7-9E51127AFC3BQ34447061-853BBF4B-4AE6-444A-94A6-17D652615F72Q34447368-8526F00F-43FC-4EE5-8EBD-159154A23A9FQ34447399-C392256B-39CE-4CBB-AD4E-7C385BAB055FQ34512316-FA71D673-C54A-4E2D-9900-F712E89B4BE7Q34512945-3F29D928-7EEF-4214-A8FF-A11929E43207Q34514198-BCB49B9E-D85F-40AE-8182-DD0D8D649A30Q34621294-1D9F4080-4FDF-4CCC-86A5-5B942AE6B979Q34622283-669BAE5A-0EF6-41E2-B5AA-6D3053F00DC2Q34675452-EB81F219-7B0B-46F0-8832-46E8CE145335Q34686236-D0568BE4-DE26-4341-8B9C-470917949824Q35070838-B999E749-CD36-449F-B1F5-09B8CF5706D3Q35137255-223354AE-7F52-47E4-8D6C-90C30D5B1B81Q35236395-F73B8EF7-F038-48CC-B875-FD8D64B44DE8Q35802793-B9FFFA08-713E-4573-9525-901D05070C8FQ35862379-D26468B0-8024-4A0E-9E2A-22D9201C6CCDQ36055037-103C55A9-16E5-4384-8434-44CAC1B008C1Q36283749-1BAC1E40-871D-4073-A78A-4FB627009495Q36581248-79F771D7-AE1D-40FA-995E-819B841848A4Q36670740-F9417D49-060A-49B8-805D-230B7117A3F9Q37084008-088A7B1B-5783-48EA-BC0A-FB156571BE8BQ37287918-A6D7B6F0-CBA8-4697-906A-C0B8DF9C3EF3Q37318017-E2FEFB8E-1E52-4B87-B794-5E01A89A8083Q37499002-B8BE0341-0B8E-4AD2-BE1B-6BA053A22CE8
P2860
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Drug therapy: drug disposition in old age.
@en
type
label
Drug therapy: drug disposition in old age.
@en
prefLabel
Drug therapy: drug disposition in old age.
@en
P2093
P1476
Drug therapy: drug disposition in old age.
@en
P2093
Greenblatt DJ
Sellers EM
P304
P356
10.1056/NEJM198205063061804
P407
P577
1982-05-01T00:00:00Z